The Latest Cardiac and Vascular News
Medtech industry veteran of two IPOs on the Nasdaq Stock Market (HeartWare, Avedro) CLICHY, France–(BUSINESS WIRE)–CorWave, a medtech company focused on the development of an innovative Left Ventricular Assist Device (LVAD) to treat patients suffering from severe heart failure, announced today the election of Jim Schuermann to its board of […]
IRVINE, Calif.–(BUSINESS WIRE)–JenaValve Technology, Inc., developer and manufacturer of the JenaValve Pericardial Transcatheter Aortic Valve Replacement (TAVR) System for the treatment of aortic valve disease, announces that it has raised $50 million in an equity financing led by Bain Capital Life Sciences. Additional participants in the financing included existing investors Andera […]
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has appointed Stephen Trowbridge to the role of Executive Vice President and Chief Financial Officer, effective February 5, 2020. Mr. Trowbridge has served as the […]
CALGARY, Alberta, Feb. 10, 2020 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM; OTC: HMTXF) is pleased to announce the appointment of Dr. Ronnie Hershman, M.D., F.C.C.S., to its Board of Directors. Dr. Hershman is a successful, practicing cardiologist with over three decades of experience. Dr. Hershman […]
February 6, 2020 at 4:05 PM EST PDF Version BURLINGTON, Mass., Feb. 06, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2019 results, provided guidance, and announced a $0.095/share dividend. Q4 2019 Results Record sales of $30.2mm, +6% (flat organic) vs. Q4 2018 Operating income […]
SUWANEE, GA, Feb. 07, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV) today announced the appointment of Dr. Tom Price to its Board of Directors. Dr. Price brings over 30 years of medical practice and knowledge to SANUWAVE. Dr. Price’s extensive experience in public service, serving the state of […]
– As reported, revenues of $4.225 billion increased 1.6 percent. – On a currency-neutral basis, revenues increased 2.5 percent. – As reported, diluted earnings per share of $0.87 decreased 57.6 percent. – As adjusted, diluted earnings per share of $2.65 decreased 1.9 percent, or 0.4 percent on a currency-neutral basis. […]
WAYNE, Pa., Feb. 06, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) announced today that financial results for the fourth quarter and full year 2019 will be released before market open on Thursday, February 20, 2020. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, February […]
Conference Call Scheduled for Today, February 5, 2020, at 3:30 PM CT (4:30 PM ET) Revenues of $68.3 million increased 13.5% from second quarter last year Net loss was $3.4 million, or $0.10 per basic and diluted share Company raises low end of fiscal 2020 revenue guidance range ST. PAUL, […]
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2020 first quarter ended December 31, 2019. Summary of First Quarter and Recent Highlights Revenue of $22.6 million, an increase of 2% […]
